Gainers
- Virax Biolabs Group (NASDAQ:VRAX) shares rose 34.2% to $0.81 during Wednesday's pre-market session. The market value of their outstanding shares is at $12.5 million.
- Genprex (NASDAQ:GNPX) stock increased by 15.78% to $1.1. The company's market cap stands at $57.1 million.
- Matinas BioPharma Hldgs (AMEX:MTNB) shares moved upwards by 14.85% to $0.58. The market value of their outstanding shares is at $126.0 million.
- VYNE Therapeutics (NASDAQ:VYNE) stock increased by 14.37% to $3.58. The market value of their outstanding shares is at $11.6 million.
- BiondVax Pharmaceuticals (NASDAQ:BVXV) stock rose 14.35% to $2.23. The market value of their outstanding shares is at $4.2 million. The company's, Q4 earnings came out 2 days ago.
- Legend Biotech (NASDAQ:LEGN) shares rose 13.89% to $59.5. The market value of their outstanding shares is at $9.8 billion.
Losers
- Femasys (NASDAQ:FEMY) stock declined by 26.2% to $0.93 during Wednesday's pre-market session. The company's market cap stands at $11.0 million.
- Allarity Therapeutics (NASDAQ:ALLR) stock decreased by 23.28% to $0.89.
- SAB Biotherapeutics (NASDAQ:SABS) stock fell 14.66% to $0.93. The company's market cap stands at $46.8 million. As per the news, the Q4 earnings report came out 3 days ago.
- Indaptus Therapeutics (NASDAQ:INDP) shares decreased by 14.11% to $2.12. The company's market cap stands at $17.8 million.
- CNS Pharma (NASDAQ:CNSP) shares declined by 12.23% to $1.79. The market value of their outstanding shares is at $3.9 million.
- Dermata Therapeutics (NASDAQ:DRMA) stock fell 9.89% to $2.28. The company's market cap stands at $1.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CNSPCNS Pharmaceuticals Inc
$6.6810.7%
DRMADermata Therapeutics Inc
$2.274.61%
FEMYFemasys Inc
$0.6227-0.42%
GNPXGenprex Inc
$2.840.02%
INDPIndaptus Therapeutics Inc
$2.71-%
LEGNLegend Biotech Corp
$19.180.89%
MTNBMatinas BioPharma Holdings Inc
Not Available-%
SABSSAB Biotherapeutics Inc
$4.01-0.74%
VRAXVirax Biolabs Group Ltd
$0.2633-%
VYNEVYNE Therapeutics Inc
$0.5701-1.79%
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
